Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Advanz Pharma
Entity

Advanz Pharma

Tracked across 1 events · 8 articles · First seen Jan 29, 2026 · Last active Jan 29, 2026

Sentiment
50
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 50
Business
Alvogen Settles Global Eylea Biosimilar Patent Disputes
Advanz Pharma is a commercial partner for Alvogen's Eylea biosimilar in the United Kingdom and European Economic Area, and is now well-positioned for a successful launch following the patent settlement.
Jan 29, 2026 · 8 articles
Relationships (1)
Alvogen commercial partner ↔ Advanz Pharma Advanz Pharma is a commercial partner for Alvogen's Eylea biosimilar in Europe.
NEWSDESK
Track Advanz Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.